Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Atai Life Sciences N.V.
(NQ:
ATAI
)
1.300
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Atai Life Sciences N.V.
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
26
27
Next >
Dow Rises 150 Points; Mission Produce Shares Slide
December 23, 2022
U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining around 150 points on Friday.
Via
Benzinga
Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
December 23, 2022
Gainers
Via
Benzinga
Dow Surges Over 100 Points; Crude Oil Rises Sharply
December 23, 2022
U.S. stocks traded mostly higher midway through trading, with the Dow Jones gaining over 100 points on Friday.
Via
Benzinga
Cybin, ATAI Life Sciences Among Top Psychedelic Movers Of Today
December 22, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From December 21, 2022
December 21, 2022
Via
Benzinga
GH Research, Seelos Therapeutics Among Top Psychedelic Movers Of Today
December 20, 2022
Via
Benzinga
atai Life Sciences Announces Results from the Kures Therapeutics Phase 1 Trial of KUR-101
December 23, 2022
From
atai Life Sciences
Via
GlobeNewswire
3 (Risky) Tricks for Finding Monster Growth Stocks
December 21, 2022
Stocks with big upside potential often have significant risks, too.
Via
The Motley Fool
ATAI Life Sciences's Return On Capital Employed Insights
December 20, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From December 19, 2022
December 19, 2022
Via
Benzinga
atai Life Sciences Initiates Phase 2b proof-of-concept trial of RL-007 for Cognitive Impairment Associated with Schizophrenia
December 19, 2022
From
atai Life Sciences
Via
GlobeNewswire
Psychedelic Stock Gainers And Losers From December 14, 2022
December 14, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From December 13, 2022
December 13, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From December 9, 2022
December 09, 2022
Via
Benzinga
Major Psychedelic Drug Stocks Down Another 7% This Week; Now Down 54% YTD
December 18, 2022
The 6 largest psychedelic stocks that research the treatment of a variety of mental illnesses based on the use of 10 different psychedelic substances are down again this week.
Via
Talk Markets
Seelos Therapeutics, Mind Medicine Among Top Psychedelic Movers Of Today
December 16, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2022
December 16, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From December 7, 2022
December 07, 2022
Via
Benzinga
The atai Fellowship Fund in Psychedelic Neuroscience Announces its First Cohort at Massachusetts General Hospital
December 16, 2022
From
atai Life Sciences
Via
GlobeNewswire
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today
December 15, 2022
Via
Benzinga
EXCLUSIVE: Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans
December 15, 2022
Part one of a three-part series. The first medical-grade drug candidate of the psychedelic ayahuasca is being developed.
Via
Benzinga
Psychedelic Stock Gainers And Losers From December 12, 2022
December 12, 2022
Via
Benzinga
Major Psychedelic Drug Stocks DOWN 9% Last Week; Now Down 51% YTD
December 11, 2022
Today's article highlights the performance of the largest psychedelic stocks that research the treatment of a variety of mental illnesses based on the use of ten (10) different psychedelic substances.
Via
Talk Markets
Compass Pathways, Mind Medicine Among Top Psychedelic Movers Of Today
December 08, 2022
Via
Benzinga
Seelos Therapeutics, Numinus Wellness Among Top Psychedelic Movers Of Today
December 06, 2022
Via
Benzinga
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today
December 05, 2022
Via
Benzinga
Major Psychedelic Drug Stocks Went Up 7% This Week; Still Down 46% YTD
December 03, 2022
The 6 major psychedelic stocks researching the treatment of a variety of mental illnesses were UP 7% this week and are UP 3 % in the last 6 weeks. The 6 therapy clinic stocks went UP 3% this week and...
Via
Talk Markets
Psychedelic Stock Gainers And Losers From December 2, 2022
December 02, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From December 1, 2022
December 01, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 30, 2022
November 30, 2022
Via
Benzinga
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
26
27
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.